DaVita
DVA
#1819
Rank
S$14.61 B
Marketcap
S$232.34
Share price
-3.08%
Change (1 day)
50.05%
Change (1 year)
DaVita Inc. is an American company providing dialysis services for patients with chronic and acute kidney failure.

EPS for DaVita (DVA)

EPS in 2026 (TTM): S$16.08

According to DaVita's latest financial reports the company's current EPS (TTM) is S$15.96. In 2025 the company made an earnings per share (EPS) of S$12.94 a decrease over its 2024 EPS that were of S$14.10.

EPS history for DaVita from 2012 to 2026

Annual EPS

Year EPS Change
2026 (TTM)S$16.0824.27%
2025S$12.94-8.25%
2024S$14.1044.94%
2023S$9.7327.26%
2022S$7.65-35.56%
2021S$11.8644.1%
2020S$8.2319.7%
2019S$6.88540.48%
2018S$1.07-76.07%
2017S$4.49-19.31%
2016S$5.56242.52%
2015S$1.62-62.87%
2014S$4.3713.43%
2013S$3.858.45%
2012S$3.55

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Universal Health Services
UHS
S$31.75 98.96%๐Ÿ‡บ๐Ÿ‡ธ USA
LabCorp
LH
S$15.56-2.48%๐Ÿ‡บ๐Ÿ‡ธ USA
Tenet Healthcare
THC
S$33.40 109.29%๐Ÿ‡บ๐Ÿ‡ธ USA
Pediatrix Medical Group
MD
S$2.71-83.04%๐Ÿ‡บ๐Ÿ‡ธ USA